Clinical trial

Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With…

NCT01381172 · Impulse Dynamics, Industry · Completed

Key facts

NCT number NCT01381172
Title Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Official title Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Acronym FIX-HF-5C
Lead sponsor Impulse Dynamics, Industry
Status Completed
Study type Interventional
Conditions NYHA Class III Heart Failure, NYHA Class IV Heart Failure
Intervention type Device, Other
Interventions Optimizer System, No intervention: Optimal medical therapy
Enrollment 160
Start date Jan 1, 2011
Primary completion Mar 19, 2019
Completion Mar 19, 2019
First posted Jun 27, 2011
Last update posted Sep 17, 2021
Countries Czechia, Germany, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies